News & Updates

Doctor’s judgement falls short for assessing frailty in elderly cancer patients

27 Sep 2020

The physician’s clinical judgement is insufficient for the assessment of frailty among elderly cancer patients, and should be complemented with more structured tools, such as the geriatric assessment, a recent study has found

Doctor’s judgement falls short for assessing frailty in elderly cancer patients

27 Sep 2020

Nivolumab-ipilimumab displays potential in malignant pleural mesothelioma

24 Sep 2020 by

For patients with unresectable malignant pleural mesothelioma (MPM), nivolumab plus ipilimumab in the first-line setting demonstrated greater overall survival (OS) than standard-of-care (SoC) platinum chemotherapy, interim analysis of the phase III CheckMate743 trial revealed.

Nivolumab-ipilimumab displays potential in malignant pleural mesothelioma

24 Sep 2020

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

24 Sep 2020

A novel nomogram that includes liver stiffness measurements may help predict postoperative complications in hepatocellular carcinoma (HCC) patients, a recent study has found.

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

24 Sep 2020

Venetoclax-azacitidine duo may benefit older patients with AML

24 Sep 2020 by

The addition of venetoclax to azacitidine improved survival and remission rates in previously untreated adults with acute myeloid leukaemia (AML) who were ineligible for intensive induction chemotherapy (CT), the VIALE-A trial has shown.

Venetoclax-azacitidine duo may benefit older patients with AML

24 Sep 2020

Selpercatinib shows promise in RET-mutant medullary thyroid cancer

24 Sep 2020

Selective RET inhibition with selpercatinib has demonstrated durable efficacy with low-grade toxicity in medullary thyroid cancer patients harbouring RET mutation, according to the results of a phase I–II trial.

Selpercatinib shows promise in RET-mutant medullary thyroid cancer

24 Sep 2020

Exercise seems ineffective to boost bone mineral density while on ADT

23 Sep 2020

Moderate-intensity aerobic and resistance exercises may not be enough to attenuate the negative effects of androgen deprivation therapy (ADT) on metabolic markers and bone mineral density in older men with prostate cancer, a recent study has found.

Exercise seems ineffective to boost bone mineral density while on ADT

23 Sep 2020

Primary Sjögren syndrome bidirectionally linked to non-Hodgkin lymphoma

23 Sep 2020

A bidirectional relationship is observed between primary Sjögren syndrome (pSS) and non-Hodgkin lymphoma (NHL), reports a nationwide population-based study in Taiwan.

Primary Sjögren syndrome bidirectionally linked to non-Hodgkin lymphoma

23 Sep 2020

Whole grain intake lowers risk of colorectal cancer

23 Sep 2020 by

Higher consumption of whole grains and fibre from grains, but not total intake of dietary fibre, may reduce the risk of colorectal cancer (CRC), a recent study has shown.

Whole grain intake lowers risk of colorectal cancer

23 Sep 2020

Prophylactic nipple‐sparing mastectomy safe, feasible in high-risk breast cancer

19 Sep 2020

Use of bilateral prophylactic nipple-sparing mastectomy (NSM) appears to be safe in patients with high-risk breast cancer, a study has shown.

Prophylactic nipple‐sparing mastectomy safe, feasible in high-risk breast cancer

19 Sep 2020

Use of 5α-reductase inhibitors does not affect Gleason grading

16 Sep 2020

A recent study has found no significant impact of 5α-reductase inhibitors on Gleason grading, with no difference in mortality seen among users and nonusers in each Gleason group.

Use of 5α-reductase inhibitors does not affect Gleason grading

16 Sep 2020

News & Updates

Filter by Specialty:

Specialty:

Doctor’s judgement falls short for assessing frailty in elderly cancer patients

Doctor’s judgement falls short for assessing frailty in elderly cancer patients

Nivolumab-ipilimumab displays potential in malignant pleural mesothelioma

Nivolumab-ipilimumab displays potential in malignant pleural mesothelioma

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

Adding liver stiffness into nomogram boosts predictive value for postoperative complications in HCC

Venetoclax-azacitidine duo may benefit older patients with AML

Venetoclax-azacitidine duo may benefit older patients with AML

Selpercatinib shows promise in RET-mutant medullary thyroid cancer

Selpercatinib shows promise in RET-mutant medullary thyroid cancer

Exercise seems ineffective to boost bone mineral density while on ADT

Exercise seems ineffective to boost bone mineral density while on ADT

Primary Sjögren syndrome bidirectionally linked to non-Hodgkin lymphoma

Primary Sjögren syndrome bidirectionally linked to non-Hodgkin lymphoma

Whole grain intake lowers risk of colorectal cancer

Whole grain intake lowers risk of colorectal cancer

Prophylactic nipple‐sparing mastectomy safe, feasible in high-risk breast cancer

Prophylactic nipple‐sparing mastectomy safe, feasible in high-risk breast cancer

Use of 5α-reductase inhibitors does not affect Gleason grading

Use of 5α-reductase inhibitors does not affect Gleason grading